Methicillin-resistant S. aureus infections among patients in the emergency department.
暂无分享,去创建一个
Roberta B Carey | D. Talan | G. Moran | L. Mcdougal | A. Krishnadasan | R. Carey | G. Fosheim | R. Gorwitz | Gregory J Moran | Linda K McDougal | Anusha Krishnadasan | Rachel J Gorwitz | Gregory E Fosheim | David A Talan | L. McDougal
[1] D. Nathwani. Tigecycline: clinical evidence and formulary positioning. , 2005, International journal of antimicrobial agents.
[2] Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. , 2003, MMWR. Morbidity and mortality weekly report.
[3] J. Garner. Guideline for isolation precautions in hospitals. Part II. Recommendations for isolation precautions in hospitals. Hospital Infection Control Practices Advisory Committee. , 1996, American journal of infection control.
[4] R. Dolin,et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus , 2004 .
[5] D. Lauderdale,et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.
[6] S. Boyle-Vavra,et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. , 2005, The New England journal of medicine.
[7] D. Talan,et al. Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections , 2005, Emerging infectious diseases.
[8] Garner Js. Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee , 1996 .
[9] D. Holland,et al. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. , 2001, The Journal of antimicrobial chemotherapy.
[10] C. Carpenter,et al. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] J. Lamar,et al. Community-acquired Methicillin-resistant Staphylococcus aureus among Military Recruits , 2004, Emerging infectious diseases.
[12] J. Kaneko,et al. The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Arjun Srinivasan,et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. , 2005, The New England journal of medicine.
[14] K. Itani,et al. Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections , 2005, Antimicrobial Agents and Chemotherapy.
[15] Teruyo Ito,et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. , 2002, The Journal of infectious diseases.
[16] P. Stankiewicz,et al. Emergence of a Predominant Clone of Community-Acquired Staphylococcus aureus Among Children in Houston, Texas , 2005, The Pediatric infectious disease journal.
[17] F. Vandenesch,et al. Frequent Carriage of Panton-Valentine Leucocidin Genes by Staphylococcus aureus Isolates from Surgically Drained Abscesses , 2005, Journal of Clinical Microbiology.
[18] Amy V. Groom,et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] S. Kaplan,et al. Severe Staphylococcal Sepsis in Adolescents in the Era of Community-Acquired Methicillin-Resistant Staphylococcus aureus , 2005, Pediatrics.
[20] R. Lynfield,et al. Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.
[21] K. Carroll,et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] H. Chambers,et al. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. , 1991, Infection control and hospital epidemiology.
[23] F. Vandenesch,et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] R. Daum,et al. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] Susan K. Johnson,et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.
[26] M. Rybak,et al. Community‐Associated Methicillin‐Resistant Staphylococcus aureus: A Review , 2005, Pharmacotherapy.
[27] J. Bonnetblanc,et al. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. , 1989, Archives of dermatology.
[28] S. Kaplan. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. , 2005, The Pediatric infectious disease journal.
[29] S. McAllister,et al. Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database , 2003, Journal of Clinical Microbiology.
[30] G. Mccracken,et al. Inducible Clindamycin Resistance and Molecular Epidemiologic Trends of Pediatric Community-Acquired Methicillin-Resistant Staphylococcus aureus in Dallas, Texas , 2005, Antimicrobial Agents and Chemotherapy.
[31] E. Charlebois,et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. , 2005, Annals of emergency medicine.
[32] L. Slutsker,et al. EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] S. Kaplan,et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children , 2003, The Pediatric infectious disease journal.
[34] M. Finland,et al. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. , 1968, The New England journal of medicine.
[35] Mian Cai,et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] G. Sensabaugh,et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. , 2005, The Journal of infectious diseases.